Category: Greece

New Scientific Publication with the Participation of Kapa3: Cancer Survivorship in the Post-COVID-19 Era

New scientific publication involving the Cancer Patient Guidance Center – Kapa3 highlights the significant psychological, social, and functional challenges that people living with and beyond cancer continue to face following the COVID-19 pandemic.

The article, entitled “Cancer Survivorship After COVID-19: Psychological Burden, Symptom Experience, and Social Support,” was published in the international peer-reviewed journal Medicina. It examines psychological distress, symptom experience, quality of life, and the protective role of social support among people affected by cancer.

What Did the Study Examine?

The research involved 162 adults diagnosed with cancer in Greece during the post-COVID-19 period. Participants completed validated questionnaires assessing depression, anxiety, stress, health-related quality of life, and perceived social support.

The results revealed a substantial and persistent psychological burden:

  • 32.1% of participants reported severe or extremely severe depression.
  • 40.1% reported severe or extremely severe anxiety.
  • 29% reported severe or extremely severe stress.

The overall quality of life of participants was found to be moderate. Emotional and social functioning were among the most affected areas, while fatigue, insomnia, breathlessness, and financial difficulties emerged as some of the most significant challenges in everyday life.

The Close Relationship Between Mental Health and Quality of Life

One of the study’s key findings was the strong relationship between psychological distress and poorer quality of life.

Higher levels of depression, anxiety, and stress were associated with:

  • poorer daily and functional performance;
  • lower perceived overall health;
  • greater symptom severity;
  • increased difficulty in emotional and social functioning.

The results demonstrate that psychological well-being cannot be separated from the physical, social, and practical experience of cancer.

Social Support as a Protective Factor

At the same time, the study underlines the important protective role of social support.

Support from family members, friends, and other significant people was associated with better overall health and functioning, lower levels of depression, anxiety, and stress, and reduced symptom burden.

The findings show that social connection is not simply an additional element of care. It is a meaningful component of recovery, adaptation, and quality of life throughout the cancer journey.

Cancer Survivorship Does Not End When Treatment Is Completed

The findings reinforce the need to move beyond a model of oncology care focused exclusively on treating the disease.

Cancer survivorship requires a comprehensive, person-centred approach that addresses the physical, psychological, social, functional, and financial dimensions of life with and after cancer.

Routine psychological assessment, early identification of emotional distress, timely referral to psycho-oncology services, rehabilitation, social support, and the meaningful involvement of families and caregivers should become integral parts of standard oncology care.

The study also points to the potential value of telehealth and digital support services in improving access to supportive care. At the same time, it highlights inequalities related to digital literacy, healthcare accessibility, and the ability of all patients to benefit equally from digital services.

The experience of the COVID-19 pandemic demonstrated that effective cancer care must be resilient, accessible, multidisciplinary, and capable of maintaining continuity even during periods of crisis.

Read more medicina-4429149

“Myrto” under Scientific Evaluation: Transparency, Evidence and Human Oversight in Social Navigation for Oncology Patients

“Myrto” under Scientific Evaluation: Transparency, Evidence and Human Oversight in Social Navigation for Oncology Patients

The first closed scientific testing workshop of the Digital Health and Social Rights Navigator has been completed

Athens, 6 July 2026

The first closed scientific testing and evaluation workshop of “Myrto”, the Digital Health and Social Rights Navigator developed by the Cancer Patient Guidance Centre – Kapa3, was successfully completed.

The workshop was organised by the Cancer Patient Guidance Centre – Kapa3, with the support of René Descartes – Cnam College and the participation of SimasiaAI. It functioned as a dynamic scientific co-design workshop, bringing together specialised professionals from the fields of healthcare, social care, information technology and personal data protection.

The process was closed and strictly experimental in nature and did not constitute a public presentation of a completed product. Its purpose was to evaluate the behaviour of the application through hypothetical and fully anonymised scenarios, to record correct responses and areas requiring improvement, and to use expert feedback for the next phase of development.

The project “Myrto – Health and Social Rights Navigator” is being developed as a knowledge-based digital social navigation system, guided by the principles of explainable, transparent and human-centred Artificial Intelligence.

Its aim is to transform complex legal, administrative and social information into clear, evidence-based and practically useful guidance for oncology patients, caregivers and citizens.

“Myrto” does not replace professional social, legal, medical or clinical judgement. It operates as a supportive information and navigation tool, with clearly defined functional boundaries, human oversight and the possibility of referral to the competent services and professionals of Kapa3.

The programme is implemented with the support of the TIMA Charitable Foundation.

From Information to Understandable Knowledge

During the workshop, the need that led to the creation of “Myrto” was presented, along with the real barriers faced by patients and caregivers when seeking information on social rights, benefits and administrative procedures.

Particular emphasis was placed on addressing digital and informational exclusion. “Myrto” is designed to transform fragmented and often difficult-to-understand information into simple, structured and comprehensible guidance.

A Thematically Specialised and Curated Knowledge Base

The project’s technical partner, SimasiaAI, presented the operation of the application and the architecture used for information retrieval and synthesis.

“Myrto” uses a hybrid search mechanism that combines text retrieval and semantic search techniques, with the aim of identifying the information most relevant to the user’s question. The application operates on a thematically specialised and curated knowledge base.

A central element of its design is the traceability of information, namely the ability to link an answer to the source on which it is based. The use of validated sources reduces the risk of unsupported responses and enables the identification, review and correction of issues through a process of continuous maintenance, regular updating and adaptation to evolving guidelines and regulatory requirements.

Explainability and Human-Understandable Answers

The evaluation did not focus only on whether “Myrto” retrieves the correct information, but also on whether it can present that information in a clear, understandable and conceptually coherent way.

This approach strengthens trust, responsible use of the tool and the meaningful empowerment of citizens through a response-generation system that supports a transparent, evidence-based and human-supervised knowledge ecosystem, in which every piece of information is understandable, verifiable and connected to its source.

Data Protection and Compliance by Design

Personal data protection and regulatory compliance are embedded from the design stage of the application, in accordance with the principles of data protection by default and by design.

During the workshop, only hypothetical or fully anonymised cases were used. Particular emphasis was placed on the principles of data minimisation, anonymisation and secure processing. These principles are directly linked to contemporary requirements for the responsible development of Artificial Intelligence systems, the protection of special categories of data and compliance with the European regulatory framework.

Live Testing of Hypothetical Scenarios

The professionals who participated in the workshop tested the application individually and in small groups, using only hypothetical and fully anonymised cases. The testing was based on an approach that evaluated the behaviour of the system, examining not only whether the final answer was correct, but also whether the overall operation of the application was safe, understandable and appropriate for the specific request.

Disability Certification through KEPA

In one of the key scenarios, “Myrto” was asked to guide a hypothetical patient who did not know how to start the disability certification procedure through KEPA. The system retrieved the main steps of the process, organised the information in an understandable format and provided relevant references to the sources.

Participants evaluated:

  • the accuracy of the information,
  • the completeness of the steps,
  • the clarity of the language,
  • and the practical usefulness of the answer.

Travel from the Region for Treatment

In a second scenario, the case of an oncology patient who needed to travel from the region to another location for treatment was examined. The application identified relevant categories of socioeconomic support and benefits and presented possible next steps to the user.

The test allowed participants to assess:

  • the correct identification of the request,
  • the connection between different rights and benefits,
  • the completeness of the sources,
  • and the possibility of referral to the appropriate services.

At the same time, cases were also examined in which:

  • the question was unclear or incomplete,
  • the user did not know which right or benefit to look for,
  • clarifying questions were required,
  • medical or personalised legal advice was requested,
  • or immediate human intervention was necessary.

A Continuous Cycle of Scientific Feedback

The meeting concluded with a discussion of the testing results, a review of the technical logs and the presentation of key usage statistics for the application.

The participants’ observations are not treated as isolated comments, but as structured scientific feedback for improvement. In this way, a closed cycle of learning and feedback is created, in which technology, scientific knowledge and the experience of professionals interact continuously.

The continuous involvement of experts and the integration of structured feedback are considered critical for strengthening transparency, reliability and trust in Artificial Intelligence systems used in sensitive fields.

The Interdisciplinary Project Team

The development, scientific documentation and regulatory compliance of “Myrto” are supported by an interdisciplinary team from the fields of health services administration, information technology, personal data protection, language technology and software development. The workshop was attended by:

Evangeli Bista, Co-founder of Kapa3 and Head of Strategic Partnerships; Aristea Archontidou, Industrial Informatics Engineer with postgraduate specialisation in Health Policy and Health Services Planning; Anastasia Vlachopoulou, lawyer and member of the Thessaloniki Bar Association, specialised in personal data protection; Dimitris Papadakis, Co-founder and Sales Manager at SimasiaAI and Project Manager of the “Myrto” project; and Giannis Barous, Co-founder and CTO of SimasiaAI, PhD candidate in Computer Science based in San Francisco, who has undertaken the technical component of the project: how the system identifies the right information, how it connects it with reliable sources and how it provides answers that are evidence-based, useful and safe.

About Kapa3

The Cancer Patient Guidance Centre – Kapa3 is a social support, information and navigation organisation for oncology patients, survivors, caregivers and their families. Its aim is to contribute to equal access to oncology care, social protection and the rights associated with the cancer experience.

Every day, Kapa3 supports people who face not only the disease itself, but also a range of practical, administrative, social and psychosocial challenges. Through personalised social guidance, the organisation helps patients and caregivers learn about their rights, understand available benefits and services, navigate administrative procedures and connect with appropriate support structures.

The main pillars of Kapa3’s work include information on social and insurance rights, support in accessing health and social care services, guidance on benefits and procedures, empowerment of patients and caregivers, and connection with professionals, organisations and communities.

As part of its digital strategy, Kapa3 develops digital empowerment and social navigation tools, such as “Myrto”, the Digital Health and Social Rights Navigator. “Myrto” is designed to transform complex legal, administrative and social information into clear and evidence-based guidance for oncology patients, caregivers and citizens, always with human oversight, transparency and respect for the limits of technology.

Kapa3’s philosophy is based on the principle that care is not limited to medical treatment. It includes access to information, social protection, psychosocial support, dignity, empowerment and the ability of every person to know and claim their rights.

Through collaborations with health and social care professionals, academic and research institutions, civil society organisations, public structures, volunteers and communities, Kapa3 seeks to build bridges between the patient, information, services and real access.

Ηλικία, φύλο και ανοσοποιητικό σύστημα τα στοιχεία που αυξάνουν τον κίνδυνο θανάτου από covid19

Cancer Immunotherapy: A Revolution That Continues to Transform Cancer Care

Over the past fifteen years, cancer immunotherapy has transformed the landscape of oncology, offering new hope and treatment possibilities to patients around the world. What began as a promising scientific concept has evolved into one of the most important pillars of modern cancer treatment.

According to the Cancer Immunotherapy Insights & Impact Report 2026 published by the Cancer Research Institute, a total of 156 immunotherapy approvals were granted by the U.S. Food and Drug Administration (FDA) between 2011 and 2025, reflecting the remarkable growth and impact of this field. Many of these therapies are based on immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells more effectively.

Unlike traditional treatments such as chemotherapy and radiation therapy, immunotherapy works by empowering the body’s own immune system to fight cancer. By enhancing natural immune responses, these therapies can help the body identify and destroy cancer cells that might otherwise evade detection. For many patients, immunotherapy has led to longer survival, improved disease control, and a better quality of life.

The year 2025 marked another milestone in the advancement of cancer immunotherapy, with thirteen new FDA approvals. Notably, patients with anal cancer gained access to their first approved immunotherapy option, highlighting the expanding reach of these innovative treatments. New methods of administration, including subcutaneous therapies, are also making treatment more convenient and accessible for patients.

Research in cancer immunotherapy continues to progress at an extraordinary pace. Scientists are developing new strategies to overcome the mechanisms that allow cancer to hide from the immune system, while exploring novel therapeutic targets, combination treatments, and personalized approaches to care. These advances aim to increase the number of patients who can benefit from immunotherapy and improve outcomes across a wider range of cancers.

While challenges remain and not all patients respond equally to treatment, immunotherapy represents one of the most significant breakthroughs in the history of cancer care. Ongoing scientific innovation continues to bring hope that more effective, personalized, and accessible treatments will become available in the years ahead.

At KAPA3, we recognize the importance of raising awareness about advances in cancer treatment and supporting informed decision-making. Knowledge empowers patients, families, caregivers, and healthcare professionals, helping them navigate the cancer journey with greater confidence and hope.

Source: https://www.cancerresearch.org/cancer-immunotherapy-report-2026

 

Memorandum of Understanding between the University of West Attica—specifically the Department of Occupational Therapy—and the NGO KAPA3.

On Tuesday, June 9, a meeting was held to sign a Memorandum of Understanding between the University of West Attica—specifically the Department of Occupational Therapy—and the NGO KAPA3.

The meeting was attended by the Rector of the University of West Attica, Panagiotis Kaldis Penelope Vlotinou, Assistant Professor in the Department of Occupational Therapy Evangelia Bista, co-founder of the organization, as well as representatives from both organizations, including the interdisciplinary team of KAPA3: Despoina Chrysostomou, Psychologist Katerina Georgiopoulou, Social Worker Yiannis Kontogiorgis, Psychologist, and Eleftheria-Irini Polyzoti, an intern from the Department of Social and Educational Policy, as well as students from the Occupational Therapy Department.

During the meeting, a constructive discussion took place regarding the prospects for cooperation between the two organizations, with the aim of developing joint actions and initiatives that will contribute to strengthening education, research, social contribution, and the connection between the academic community and society.

In this context,  it was decided in April to jointly organize a major scientific conference, which will focus on an interdisciplinary and holistic approach to health, on combating social inequalities in healthcare, as well as on the management of chronic disease. The aim of this initiative is to raise community awareness, facilitate the exchange of expertise among professionals and scientific bodies, and disseminate scientific knowledge and information to the general public.

Special mention was made of the innovative work of KAPA3, the digital Health Navigator “Myrto,” a modern artificial intelligence tool currently under development and designed to support cancer patients, their families, and their caregivers. “Myrto” will function as a digital assistant (Chatbot) and Health and Rights Navigator, providing immediate, reliable, and personalized information on health, social welfare, rights, benefits, and available support services. The project aims to empower patients, improve their access to information, and reduce inequalities in health and social care through the use of digital technologies and artificial intelligence applications. The development of “Myrtos” represents a pioneering application of social artificial intelligence in the field of oncology care in Greece and is part of KAPA3’s strategy to promote innovation, accessibility, and the active participation of patients in managing their own health.

The meeting concluded in a particularly positive atmosphere of mutual appreciation and recognition. In this context, the Department of Occupational Therapy at the University of West Attica made a symbolic gesture toward the representative of KAPA3, Evangelia Bista, presenting her with a commemorative gift as a token of appreciation for her many years of valuable social contribution in the field of support for cancer patients. At the same time, as a gesture of hospitality and appreciation, the team was offered a specially produced wine, which is an original creation of the University of West Attica.

 

 

May, Melanoma Awareness Month: Prevention, awareness and early diagnosis

May is internationally recognized as Melanoma Awareness Month and Skin Cancer Awareness Month, dedicated to raising awareness about prevention, sun protection, and the importance of early diagnosis.

Skin cancer is the most common type of cancer worldwide, with melanoma being its most aggressive form. Although it accounts for a smaller proportion of skin cancer cases, it is responsible for the majority of skin cancer-related deaths.

Globally, in 2020 there were approximately 325,000 new cases of melanoma and around 57,000 deaths, with numbers expected to rise in the coming years if prevention and awareness efforts are not strengthened.

In Europe, melanoma remains one of the most common cancers, with more than 100,000 new cases annually and over 15,000 deaths each year. The incidence is higher in Northern and Western European countries, while overall UV radiation exposure is considered the main contributing factor for the majority of cases.

Excessive exposure to ultraviolet (UV) radiation, whether from the sun or artificial sources such as tanning beds, is the most significant risk factor for melanoma. Many cases could be prevented through proper sun protection and behavioral changes.

In countries like Greece, where sunlight exposure is high throughout much of the year, awareness and prevention are especially important. Regular skin self-examinations and dermatological check-ups can play a key role in identifying suspicious changes in moles (naevi) at an early stage.

Early diagnosis significantly improves survival rates. When detected in its initial stages, melanoma is highly treatable, whereas delayed diagnosis is associated with more aggressive disease progression. This highlights the critical importance of awareness and timely medical evaluation.

Preventive measures remain essential: using sunscreen, avoiding peak sun hours, wearing protective clothing, and avoiding artificial tanning can all significantly reduce risk.

Melanoma Awareness Month serves as an important reminder that skin health is not only an aesthetic concern but a vital part of overall health and cancer prevention.

Read also Kapa3’s article on Bladder Cancer Awareness Month.

Sources:

  • World Health Organization (WHO)
  • International Agency for Research on Cancer (IARC) – GLOBOCAN
  • European Cancer Information System (ECIS)
  • European Environment Agency (EEA)

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

EOPYY: New reimbursement framework for respiratory devices – What changes for patients

The reimbursement of respiratory devices under EOPYY has been updated through a new decision published in the Government Gazette (FEK) on April 27, 2026.

On April 27, 2026, a new EOPYY decision was published in the Government Gazette, establishing revised reimbursement prices for respiratory devices such as CPAP, Auto CPAP, and BiPAP machines.

These are medical devices primarily used by patients with respiratory disorders, including sleep apnoea, and they represent a fundamental part of daily treatment and quality of life.

EOPYY reimbursement for respiratory devices: what changes

With this regulation:

  • specific reimbursement prices are defined for each category of respiratory device
  • the prices apply to all products included in the Reimbursed Medical Devices Register
  • previous decisions for the same categories are replaced

Prices are unified per device category, regardless of manufacturer or commercial model.

What this means for patients

The new EOPYY reimbursement framework for respiratory devices provides a clearer structure for people living with respiratory conditions who depend on these devices in their daily lives:

  • it clarifies what is covered by EOPYY
  • it strengthens transparency regarding equipment costs
  • it ensures access to essential therapeutic tools that are not a choice, but a necessity

In some cases, a patient co-payment may apply when the device price exceeds the reimbursement amount.

Temporary nature of the regulation

The decision is considered temporary, as it is part of a transitional framework until the completion of the negotiation process for final pricing.

Nevertheless, it is fully applicable from the moment of its publication in the Government Gazette and constitutes the current reimbursement framework.

A more human perspective

Behind technical terms, codes, and regulatory tables, there are people who rely on these devices to breathe better, sleep better, and maintain a more stable daily life.

A clear reimbursement framework is not merely an administrative measure. It helps reduce uncertainty in situations that are already difficult to manage.

Source

The full text of the decision, along with the detailed list of reimbursed respiratory devices and corresponding prices, is available (in Greek) in the Government Gazette (FEK) of April 27, 2026.

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Additional Rebate on High-Cost Medicines for 2025: What the New Decision Foresees

 

 

 

MELODIC Online Symposium: completion of the pilot training phase and strengthening psychosocial cancer care

The European project MELODIC (Mental Health Support for Young Adults with Cancer), in which the Cancer Guidance Center – Kapa3 participates, is being implemented through distinct development phases. The pilot training programme for healthcare professionals is one of its core components, and within this framework, the MELODIC Online Symposium 2026, taking place on 24 April 2026, marks the completion of this educational phase.

The MELODIC project framework

MELODIC is a European project co-funded by the European Union, aiming to strengthen the mental health of young adults living with cancer, as well as to support their families. Through the collaboration of universities, research institutions and healthcare organizations across Europe, the project develops training and support tools for healthcare professionals.

More information about the project and its progress is available on the official Kapa3 website, in the dedicated project section.

The pilot training programme

The pilot training programme focused on enhancing the knowledge and skills of healthcare professionals in providing psychosocial support to young adults with cancer and their families.

As part of the programme, online sessions and contact lessons were delivered, aiming to strengthen interdisciplinary collaboration and support the practical application of tools in everyday clinical practice.

MELODIC Online Symposium 2026

The MELODIC Online Symposium 2026, a two-hour event, brings together participants from all partner countries and includes:

  • opening presentations from the European Cancer Organisation and Youth Cancer Europe
  • an “experts by experience” panel, where individuals share their lived experience
  • a networking panel with healthcare professionals from participating countries
  • discussion on how training can be applied in clinical practice
  • a closing session by the project coordination team

From training to clinical practice

A key objective of the MELODIC training programme is to strengthen the psychosocial dimension of cancer care, with particular focus on young adults.

The exchange of experiences among healthcare professionals contributes to more holistic approaches to care and supports the integration of psychosocial support into daily clinical practice.

The role of Kapa3

Kapa3 actively participates in the European MELODIC consortium, contributing to the implementation of the training activities and the dissemination of results in Greece. Through this involvement, the connection between scientific knowledge and the support of cancer patients is further strengthened, promoting the development of practical approaches to psychosocial care.

The MELODIC Online Symposium 2026 marks the transition from the pilot training phase to the next stage of utilizing its outcomes, reinforcing the link between education and real-world application in cancer care.

The Press Release here: PRESS-RELEASE-MELODIC SYMPOSIUM

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Update on Constant Attendance Allowance – March 2026

Based on the latest available data for March 2026, the Constant Attendance Allowance, provided through e-EFKA, has been increased and now reaches up to €845–846 per month, depending on the category and insurance status. This allowance applies to pensioners with severe disabilities or serious mobility impairments who require continuous assistance and supervision from another person, following disability certification by the KEPAs.

The year 2026 features increases and retroactive payments in EFKA allowances, including disability benefits, aiming to strengthen support for vulnerable pensioners and reduce financial difficulties in daily life. This adjustment reflects the ongoing commitment to support pensioners with increased care needs.

Eligible Pensioners

  • Pensioners with a disability rate above 67%, for whom continuous care by another person is certified.

  • Blind elderly pensioners.

  • Survivors’ pensioners, provided the deceased had their first insurance before 1/1/1993.

Amounts and Supplements

  • For those insured before 1/1/1993, the supplement reaches 50% of the pension, up to €671.40.

  • For those insured from 1/1/1993 onwards, the amount is €173.34.

  • Employees may also receive an extra-institutional allowance, with a total maximum of €846.

  • At a social assistance level, the amount can reach up to €380 per month.

For public sector pensioners, the corresponding supplement is calculated at 2.5% to 4.5% of the basic lieutenant salary, depending on the degree of incapacity, and in cases of 80% or higher incapacity, the amount increases by 50%. The allowance is tax-free and protected from garnishment.

Important Note: The official decision on the adjustment is expected to be published in the Government Gazette in the coming days. Once available, the article will be updated with full details and the official Gazette reference.

This increase on the Constant Attendance Allowance, forms part of the broader adjustment of social welfare allowances for 2026, confirming the commitment to support pensioners with higher self-care needs and ensure a dignified standard of living.

Text/adaptation: Ifiyenia Anastasiou for Kapa3